AMARIN, the double challenge.
Amarin faces the double challenge of the complexities of the Pharmaceutical Industry, in addition to the unfavorable scenario in macroeconomic terms in Argentina. [...]
Sergio Lucero: “Amarin differentiates itself by respecting all the rules and being flexible in dealing”
What makes it possible for Amarin, a small player, to compete in the big leagues of the transdermal market? Here are the reasons in the voice of our Director & CEO, Sergio Lucero. [...]